MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Effects of Personalized Visual and Auditory Cueing on Sit-to-Stand Biomechanics in Individuals with Parkinson’s disease: A Subgroup Analysis

    N. Charususin, P. Kantha, S. Bovonsunthonchai, R. Rojasavastera, P. Wichaidit, J. Richards, P. Jatesiktat, W. Ang, P. Srivanitchapoom, F. Khobkhun (Nakhon Pathom, Thailand)

  • Effects of Phase-Specific Vibrotactile Cueing on Spatiotemporal Gait Parameters in Parkinson’s Disease

    S. Maddumage Dona, K. Sullivan, A. Lehn, N. Kalyani, G. Kerr (Brisbane City, Australia)

  • Effects of Psychiatric Symptoms on Dystonia Risk: a Prospective Cohort and Mendelian Randomization Study

    X. Zheng, Y. Yu, S. Wang, R. Ou, H. Shang, C. Li (Chengdu, China)

  • Effects of Repetitive Deep TMS on Motor Function and Cerebral Perfusion in Parkinson’s Disease

    B. Kim, M. Chang, I. Song (Seoul, Republic of Korea)

  • Effects of Rhythmic Auditory Stimulation Combined with LSVT BIG based exercises and Task-Specific Training on Balance and Gait in Parkinson Disease

    S. Sambyal, S. Kaur, S. Kumar (Faridkot, India)

  • Effects of Targeted Memory Reactivation during Sleep on Motor Memory Consolidation in Parkinson’s Disease

    L. Micca, G. Albouy, B R. King, A. Nieuwboer, W. Vandenberghe, P. Borzée, B. Buyse, D. Testelmans, J. Nicolas, M. Gilat (Salt Lake City, USA)

  • Efficacy and Adverse Events of Tetrabenazine, Deutetrabenazine, and Valbenazine in Huntington’s Disease

    J. Patino, J. Pitton Rissardo, A. Fornari Caprara, A. Mcgarry, I. Walker, N. Rocha, A. Duker, E. Furr Stimming (Cincinnati, USA)

  • Efficacy and Safety of Ecopipam for Tourette Syndrome: A Meta analysis of Controlled Trials

    A. Achuthaprasad, J. Rissardo, J. Patino, A. Caprara, A. Mcgarry, I. Walker (Houston, USA)

  • Efficacy and Safety of GLP-1 Receptor Agonists in Parkinson’s Disease: A Meta-Analysis Integrating the 96-Week Phase 3 Exenatide Trial Results

    K. Sarhan (Mansoura, Egypt)

  • Efficacy and Safety of Inhaled and Sublingual Apomorphine for On-Demand Treatment of OFF Episodes in Parkinson’s Disease: A Meta‑Analysis of Randomized Placebo‑Controlled Trials

    J. Martinez-Lemus, J. Rissardo, J. Patino, A. Caprara, A. Mcgarry, I. Walker (Camden, USA)

  • « Previous Page
  • 1
  • …
  • 72
  • 73
  • 74
  • 75
  • 76
  • …
  • 208
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley